Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to 0.14%.

  • Century Therapeutics' Return on Capital Employed rose 2400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.61% for FY2024, which is 2500.0% down from last year.
  • As of Q3 2025, Century Therapeutics' Return on Capital Employed stood at 0.14%, which was up 2400.0% from 0.11% recorded in Q2 2025.
  • Over the past 5 years, Century Therapeutics' Return on Capital Employed peaked at 0.1% during Q1 2025, and registered a low of 0.57% during Q4 2024.
  • Its 4-year average for Return on Capital Employed is 0.32%, with a median of 0.33% in 2023.
  • As far as peak fluctuations go, Century Therapeutics' Return on Capital Employed tumbled by -1700bps in 2024, and later soared by 3300bps in 2025.
  • Quarter analysis of 4 years shows Century Therapeutics' Return on Capital Employed stood at 0.29% in 2022, then plummeted by -42bps to 0.41% in 2023, then plummeted by -41bps to 0.57% in 2024, then soared by 76bps to 0.14% in 2025.
  • Its Return on Capital Employed stands at 0.14% for Q3 2025, versus 0.11% for Q2 2025 and 0.1% for Q1 2025.